REVIEW: TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BABAMAHMOODI FARHANG; HAGHSHENAS MOHAMMADREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF CLINICAL EXCELLENCE Year:2013 | Volume:1 | Issue:1 Page(s): 1-26

Download Full-Text

Persian Verion

View:

987

Download:

Cites:

Information Journal Paper

Title

REVIEW: TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION

Author(s)

BABAMAHMOODI FARHANG | HAGHSHENAS MOHAMMADREZA | Issue Writer Certificate

Keywords

HBV INFECTIONQ3

CHRONIC HEPATITISQ2

TREATMENTQ2

HEPATOCELLULAR CARCINOMAQ2

CIRRHOSISQ3

Abstract

Hepatitis B virus (HBV) infection is a major global health problem and is a factor for progressive liver diseases such as CHRONIC HEPATITIS, CIRRHOSIS and epatocellular carcinoma.HBV is an envelope, double stranded DNA virus with a genome of approximately 3200 base pairs. It has been classified into eight major genotypes (A-H) and multiple subtypes, and HBV genotypes have distinct geographical distribution of the world. WHO estimation of HBV prevalence, suggests that there are nearly two billion people worldwide who have been infected with this virus and more than 350 million of people live with chronic infection (up to 5% of the world population), of these; near one million people die annually from complications of CHRONIC HEPATITIS B, which is the 10th leading cause of death worldwide.Throughout the world, carrier variability rate for hepatitis B infection is estimated to be 0.1% to 20%, with regions classified as having low (<2%), intermediate (2-7%) and high (>8%) endemic. In Iran, it is estimated that near 30% of population have been exposed to HBV and the endemicity is intermediate, with a carrier rate 1.3%-3.8% in the different provinces of this country. In Iran, the HBV vaccination program has been started in 1993 and after that, Iran can be considered as one of the countries with low HBV INFECTION endemicity. The most genotype circulating in some provinces of Iran were genotype D in different clinical forms of HBV INFECTIONs. The distribution of HBV genotypes may guide us in determining disease burden.It is important to have information about the epidemiology of HBV as response to therapy and vaccination to control HBV INFECTION. Therefore, its successful TREATMENT has major value in quality of life of patients infected by HBV. This study designed a systematic review of chronic HBV INFECTION to determine the successful TREATMENT and following HBV positive patients.

Cites

References

Cite

APA: Copy

BABAMAHMOODI, FARHANG, & HAGHSHENAS, MOHAMMADREZA. (2013). REVIEW: TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION. JOURNAL OF CLINICAL EXCELLENCE, 1(1), 1-26. SID. https://sid.ir/paper/401334/en

Vancouver: Copy

BABAMAHMOODI FARHANG, HAGHSHENAS MOHAMMADREZA. REVIEW: TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION. JOURNAL OF CLINICAL EXCELLENCE[Internet]. 2013;1(1):1-26. Available from: https://sid.ir/paper/401334/en

IEEE: Copy

FARHANG BABAMAHMOODI, and MOHAMMADREZA HAGHSHENAS, “REVIEW: TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION,” JOURNAL OF CLINICAL EXCELLENCE, vol. 1, no. 1, pp. 1–26, 2013, [Online]. Available: https://sid.ir/paper/401334/en

Related Journal Papers